Protalix BioTherapeutics (PLX) Revenue Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 52.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.12% |
| Dec 31, 2025 | 1.92% |
| Sep 30, 2025 | 7.97% |
| Jun 30, 2025 | 21.39% |
| Mar 31, 2025 | -14.33% |
| Dec 31, 2024 | 28.69% |
| Sep 30, 2024 | 14.21% |
| Jun 30, 2024 | 27.99% |
| Mar 31, 2024 | -30.82% |
| Dec 31, 2023 | -18.67% |
| Sep 30, 2023 | -1.39% |
| Jun 30, 2023 | 47.33% |
| Mar 31, 2023 | -23.77% |
| Dec 31, 2022 | -14.89% |
| Sep 30, 2022 | -0.15% |
| Jun 30, 2022 | -10.59% |
| Mar 31, 2022 | 15.50% |
| Dec 31, 2021 | 69.48% |
| Sep 30, 2021 | 162.95% |
| Jun 30, 2021 | 47.42% |
| Mar 31, 2021 | 35.47% |
| Dec 31, 2020 | 121.25% |
| Sep 30, 2020 | 12.76% |
| Jun 30, 2020 | 19.93% |
| Mar 31, 2020 | 136.04% |
| Dec 31, 2019 | 88.68% |
| Sep 30, 2019 | 45.04% |
| Jun 30, 2019 | 90.59% |
| Mar 31, 2019 | 148.65% |
| Sep 30, 2018 | -20.83% |
| Jun 30, 2018 | 14.51% |
| Mar 31, 2018 | 39.09% |
| Mar 31, 2017 | -37.36% |
| Dec 31, 2016 | 31.16% |
| Sep 30, 2016 | 26.92% |
| Jun 30, 2016 | -7.89% |
| Mar 31, 2016 | -42.48% |
| Sep 30, 2015 | -28.94% |
| Jun 30, 2015 | -62.88% |
| Mar 31, 2015 | -24.04% |
| Mar 31, 2014 | 17.50% |
| Dec 31, 2013 | -107.25% |
| Sep 30, 2013 | -10.48% |
| Jun 30, 2013 | 25.66% |